Second- and third-generation drugs for immuno-oncology treatment—The more the better?

Autor: Dempke, Wolfram C.M., Fenchel, Klaus, Uciechowski, Peter, Dale, Stephen P.
Zdroj: In European Journal of Cancer March 2017 74:55-72
Databáze: ScienceDirect
Externí odkaz: